Finepoint Capital LP Diversified Active

CIK: 0001608126 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 11, 2023

Total Value ($000): $289,062 (100.0% shares, 0.0% debt)

Holdings (37)

APLS APELLIS PHARMACEUTICALS INC 7.6%

Value ($000) $22,018 Shares 241,690 Est. Cost $47.12 Unrealized +83.1%

PRTA PROTHENA CORP PLC 7.5%

Value ($000) $21,665 Shares 317,300 Est. Cost $31.42 Unrealized +105.3%

ACAD ACADIA PHARMACEUTICALS INC 7.0%

Value ($000) $20,285 Shares 846,953 Est. Cost $17.65 Unrealized +25.9%

— SAGE THERAPEUTICS INC 5.8%

Value ($000) $16,822 Shares 357,765 Est. Cost $32.48 Unrealized —

FOLD AMICUS THERAPEUTICS INC 5.8%

Value ($000) $16,652 Shares 1,325,775 Est. Cost $8.32 Unrealized +42.6%

GLPG GALAPAGOS NV 5.7%

Value ($000) $16,543 Shares 406,859 Est. Cost $48.81 Unrealized —

— MORPHIC HOLDING INC 5.7%

Value ($000) $16,486 Shares 287,556 Est. Cost $57.33 Unrealized —

— SPRINGWORKS THERAPEUTICS INC 5.5%

Value ($000) $15,958 Shares 608,628 Est. Cost $13.68 Unrealized —

— CEREVEL THERAPEUTICS HLDNG I 5.4%

Value ($000) $15,658 Shares 492,545 Est. Cost $28.10 Unrealized —

MLTX MOONLAKE IMMUNOTHERAPEUTICS 5.3%

Value ($000) $15,402 Shares 302,000 Est. Cost $26.91 Unrealized 0.0%

CRNX CRINETICS PHARMACEUTICALS IN 5.0%

Value ($000) $14,371 Shares 797,527 Est. Cost $17.67 Unrealized +12.9%

SRPT SAREPTA THERAPEUTICS INC 5.0%

Value ($000) $14,367 Shares 125,457 Est. Cost $116.16 Unrealized +10.9%

ASND ASCENDIS PHARMA A/S 4.3%

Value ($000) $12,475 Shares 139,772 Est. Cost $88.65 Unrealized —

CYTK CYTOKINETICS INC 4.2%

Value ($000) $12,040 Shares 369,093 Est. Cost $40.42 Unrealized -8.5%

CLVT CLARIVATE PLC 4.1%

Value ($000) $11,888 Shares 1,247,406 Est. Cost $8.48 Unrealized 0.0%

TVTX TRAVERE THERAPEUTICS INC 4.0%

Value ($000) $11,700 Shares 761,721 Est. Cost $25.45 Unrealized -28.5%

ARVN ARVINAS INC 3.5%

Value ($000) $10,213 Shares 411,500 Est. Cost $45.99 Unrealized -44.1%

BHC BAUSCH HEALTH COS INC 3.2%

Value ($000) $9,320 Shares 1,165,000 Est. Cost $7.37 Unrealized 0.0%

RLAY RELAY THERAPEUTICS INC 3.0%

Value ($000) $8,812 Shares 701,570 Est. Cost $18.95 Unrealized -34.4%

SLDB SOLID BIOSCIENCES INC 1.7%

Value ($000) $5,037 Shares 961,251 Est. Cost $5.95 Unrealized -5.3%

— ARES ACQUISITION CORP 0.1%

Value ($000) $404 Shares 504,706 Est. Cost $0.85 Unrealized —

— BRIDGETOWN HOLDINGS LTD 0.1%

Value ($000) $222 Shares 895,000 Est. Cost $1.24 Unrealized —

— CHURCHILL CAPITAL CORP V 0.0%

Value ($000) $110 Shares 612,000 Est. Cost $1.30 Unrealized —

— CHURCHILL CAPITAL CORP VI 0.0%

Value ($000) $97 Shares 540,000 Est. Cost $1.20 Unrealized —

CLDWW FIRST LIGHT ACQUISITION GROUP INC 0.0%

Value ($000) $85 Shares 655,200 Est. Cost $0.50 Unrealized —

— CHURCHILL CAPITAL CORP VII 0.0%

Value ($000) $77 Shares 548,000 Est. Cost $0.92 Unrealized —

— ROSS ACQUISITION CORP II 0.0%

Value ($000) $74 Shares 439,666 Est. Cost $0.89 Unrealized —

CDAWF COMPASS DIGITAL ACQUISITION CORP 0.0%

Value ($000) $68 Shares 459,906 Est. Cost $0.76 Unrealized —

IVCPW SWIFTMERGE ACQUISITION CORP 0.0%

Value ($000) $48 Shares 490,000 Est. Cost $0.21 Unrealized —

— MARBLEGATE ACQUISITION CORP 0.0%

Value ($000) $41 Shares 735,000 Est. Cost $0.50 Unrealized —

— AFTERNEXT HEALTHTECH ACQUISITION CORP 0.0%

Value ($000) $32 Shares 366,666 Est. Cost $0.70 Unrealized —

— CONYERS PARK III ACQUISITION CORP 0.0%

Value ($000) $29 Shares 571,666 Est. Cost $1.04 Unrealized —

LSBWF YS BIOPHARMA CO LTD 0.0%

Value ($000) $23 Shares 489,999 Est. Cost $0.16 Unrealized —

CNDAW CONCORD ACQUISITION CORP II 0.0%

Value ($000) $16 Shares 408,333 Est. Cost $0.95 Unrealized —

— HOME PLATE ACQUISITION CORP 0.0%

Value ($000) $15 Shares 690,000 Est. Cost $0.60 Unrealized —

— BILANDER ACQUISITION CORP 0.0%

Value ($000) $9 Shares 183,749 Est. Cost $1.10 Unrealized —

— CORSAIR PARTNERING CORP 0.0%

Value ($000) $0 Shares 334,666 Est. Cost $0.76 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
APLS	APELLIS PHARMACEUTICALS INC	241,690	$22,018	7.6%	$47.12	+83.1%	COM	03753U106
PRTA	PROTHENA CORP PLC	317,300	$21,665	7.5%	$31.42	+105.3%	SHS	G72800108
ACAD	ACADIA PHARMACEUTICALS INC	846,953	$20,285	7.0%	$17.65	+25.9%	COM	004225108
—	SAGE THERAPEUTICS INC	357,765	$16,822	5.8%	$32.48	—	COM	78667J108
FOLD	AMICUS THERAPEUTICS INC	1,325,775	$16,652	5.8%	$8.32	+42.6%	COM	03152W109
GLPG	GALAPAGOS NV	406,859	$16,543	5.7%	$48.81	—	SPON ADR	36315X101
—	MORPHIC HOLDING INC	287,556	$16,486	5.7%	$57.33	—	COM	61775R105
—	SPRINGWORKS THERAPEUTICS INC	608,628	$15,958	5.5%	$13.68	—	COM	85205L107
—	CEREVEL THERAPEUTICS HLDNG I	492,545	$15,658	5.4%	$28.10	—	COM	15678U128
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	302,000	$15,402	5.3%	$26.91	0.0%	CLASS A ORD	61559X104
CRNX	CRINETICS PHARMACEUTICALS IN	797,527	$14,371	5.0%	$17.67	+12.9%	COM	22663K107
SRPT	SAREPTA THERAPEUTICS INC	125,457	$14,367	5.0%	$116.16	+10.9%	COM	803607100
ASND	ASCENDIS PHARMA A/S	139,772	$12,475	4.3%	$88.65	—	SPONSORED ADR	04351P101
CYTK	CYTOKINETICS INC	369,093	$12,040	4.2%	$40.42	-8.5%	COM NEW	23282W605
CLVT	CLARIVATE PLC	1,247,406	$11,888	4.1%	$8.48	0.0%	ORD SHS	G21810109
TVTX	TRAVERE THERAPEUTICS INC	761,721	$11,700	4.0%	$25.45	-28.5%	COM	89422G107
ARVN	ARVINAS INC	411,500	$10,213	3.5%	$45.99	-44.1%	COM	04335A105
BHC	BAUSCH HEALTH COS INC	1,165,000	$9,320	3.2%	$7.37	0.0%	COM	071734107
RLAY	RELAY THERAPEUTICS INC	701,570	$8,812	3.0%	$18.95	-34.4%	COM	75943R102
SLDB	SOLID BIOSCIENCES INC	961,251	$5,037	1.7%	$5.95	-5.3%	COM NEW	83422E204
—	ARES ACQUISITION CORP	504,706	$404	0.1%	$0.85	—	*W EXP 02/02/202	G33032122
—	BRIDGETOWN HOLDINGS LTD	895,000	$222	0.1%	$1.24	—	*W EXP 09/30/202	G1355U121
—	CHURCHILL CAPITAL CORP V	612,000	$110	0.0%	$1.30	—	*W EXP 10/29/202	17144T115
—	CHURCHILL CAPITAL CORP VI	540,000	$97	0.0%	$1.20	—	*W EXP 02/17/202	17143W119
CLDWW	FIRST LIGHT ACQUISITION GROUP INC	655,200	$85	0.0%	$0.50	—	*W EXP 03/14/202	320703119
—	CHURCHILL CAPITAL CORP VII	548,000	$77	0.0%	$0.92	—	*W EXP 02/29/202	17144M110
—	ROSS ACQUISITION CORP II	439,666	$74	0.0%	$0.89	—	*W EXP 02/01/202	G7641C114
CDAWF	COMPASS DIGITAL ACQUISITION CORP	459,906	$68	0.0%	$0.76	—	*W EXP 09/29/202	G2476C123
IVCPW	SWIFTMERGE ACQUISITION CORP	490,000	$48	0.0%	$0.21	—	*W EXP 12/13/202	G63836111
—	MARBLEGATE ACQUISITION CORP	735,000	$41	0.0%	$0.50	—	*W EXP 08/31/202	56608A113
—	AFTERNEXT HEALTHTECH ACQUISITION CORP	366,666	$32	0.0%	$0.70	—	*W EXP 99/99/999	G01109126
—	CONYERS PARK III ACQUISITION CORP	571,666	$29	0.0%	$1.04	—	*W EXP 08/12/202	21289P110
LSBWF	YS BIOPHARMA CO LTD	489,999	$23	0.0%	$0.16	—	*W EXP 03/15/202	G9845F117
CNDAW	CONCORD ACQUISITION CORP II	408,333	$16	0.0%	$0.95	—	*W EXP 99/99/999	20607U116
—	HOME PLATE ACQUISITION CORP	690,000	$15	0.0%	$0.60	—	*W EXP 09/30/202	43734R111
—	BILANDER ACQUISITION CORP	183,749	$9	0.0%	$1.10	—	*W EXP 05/19/202	09001T114
—	CORSAIR PARTNERING CORP	334,666	$0	0.0%	$0.76	—	*W EXP 07/06/202	G2540H116